BMS IM101-823 (Autoimmune Hepatitis) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about how the study drug (Abatacept) effects the health of people that have had a liver transplant and have autoimmune hepatitis.
Abatacept for Autoimmune Hepatitis
Who Can Participate in the Study?
- Have had a liver transplant
- Have been diagnosed with autoimmune hepatitis
What is Involved?
If you choose to join this study, you will:
- Get the study (Abatacept) drug once a week for 6 months (up to a year if it is helping)
- Complete follow-up visits for 1 year after stopping the study drug